Clinical Trial Results: Depression (Major/Severe)

Product Name: Ixel [milnacipran]
Date of Report: 12/1/2005
Phase: IV
Open study to evaluate the efficacy and safety of milnacipran in outpatients experiencing major depression and non-responders to SSRI therapy.

Product Name: NK1 Inhibitor [NK1 Inhibitor]
Date of Report: 12/1/2005
Phase: II
A Placebo- and Paroxetine-Controlled Study of Efficacy and Safety.

Product Name: NK1 Inhibitor [NK1 Inhibitor]
Date of Report: 1/1/2006
Phase: II
A placebo- and paroxetine-controlled study of efficacy and safety.